Skip to main content

BECTON DICKINSON & CO insider trading

BDXNYSE
$176.80-1.27 (-0.71%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+17.4%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flow

Key players

  • PTPolen Thomas E. Jr.Chairman, CEO and President0.0404%of company
  • TMTimothy M. RingDirector0.0226%of company
  • BMBilal MuhsinEVP & President Connected Care0.0152%of company
  • BLBertram L. ScottDirector0.0135%of company
  • CIChristopher Ian Montague JonesDirector0.0089%of company
  • SCShana Carol NealEVP and Chief People Officer0.0088%of company
  • CDChristopher DelOreficeEVP & Chief Financial Officer0.0084%of company
  • CFClaire FraserDirector0.0082%of company
  • MFMichael FeldEVP, Chief Revenue Officer0.0072%of company
  • RGRoland GoetteEVP and President, EMEA0.0061%of company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
BDXMichael FeldEVP, Chief Revenue OfficerOpen market sell$14K-0.4%$183.70$14KSep 28, 2026Sep 29, 2026
BDXMichael FeldEVP, Chief Revenue OfficerOpen market sell$31.1K-0.8%$188.49$31.1KAug 26, 2026Aug 27, 2026
BDXRoland GoetteEVP and President, EMEAOpen market sell$441K-12.8%$180.84$441KAug 11, 2026Aug 12, 2026
BDXMichael FeldEVP, Chief Revenue OfficerOpen market sell$11.8K-0.4%$157.13$11.8KJul 27, 2026Jul 28, 2026
BDXMichael FeldEVP, Chief Revenue OfficerOpen market sell$11.5K-0.4%$152.80$11.5KJun 26, 2026Jun 26, 2026
BDXMichael David GarrisonEVP & Pres Med.Essntl&BioPharmOpen market sell$160K-7.7%$145.66$160KJun 24, 2026Jun 25, 2026
BDXMichael David GarrisonEVP & Pres Med.Essntl&BioPharmOpen market sell$167K-7.2%$151.48$167KJun 10, 2026Jun 11, 2026
BDXMichael FeldEVP, Chief Revenue OfficerOpen market sell$11.1K-0.4%$147.35$11.1KMay 26, 2026May 27, 2026
BDXMichael FeldEVP, Chief Revenue OfficerOpen market sell$11.2K-0.4%$151.94$11.2KApr 27, 2026Apr 28, 2026
BDXMichael FeldEVP, Chief Revenue OfficerOpen market sell$11.8K-0.4%$156.83$11.8KMar 26, 2026Mar 27, 2026
BDXMichael FeldEVP, Chief Revenue OfficerOpen market sell$13.6K-0.4%$181.84$13.6KFeb 26, 2026Feb 27, 2026
BDXBertram L. ScottDirectorOpen market sell$174K-2.5%$182.61$174KFeb 18, 2026Feb 18, 2026
BDXMichael FeldEVP, CRO & Pres. Life SciencesOpen market sell$15.2K-0.5%$202.73$15.2KJan 26, 2026Jan 28, 2026
BDXMichael FeldEVP, CRO & Pres. Life SciencesOpen market sell$14.5K-0.5%$196.08$14.5KDec 26, 2025Dec 29, 2025
BDXMichael David GarrisonEVP & Pres Med.Essntl&BioPharmOpen market sell$123K-4.6%$196.03$123KDec 17, 2025Dec 17, 2025
BDXMichael FeldEVP, CRO & Pres. Life SciencesOpen market sell$14.5K-0.5%$193.36$14.5KDec 1, 2025Dec 2, 2025
BDXBertram L. ScottDirectorOpen market sell$38.3K-0.6%$176.58$38.3KNov 7, 2025Nov 7, 2025
BDXMichael FeldEVP & President, Life SciencesOpen market sell$10.6K-0.7%$186.01$10.6KOct 27, 2025Oct 28, 2025
End of history · 18 transactions
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.